Literature DB >> 15671872

A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Bernard Le Foll1, Jorge Diaz, Pierre Sokoloff.   

Abstract

Environmental stimuli associated with a single cocaine exposure acquire long-lasting motivational properties that are able to induce relapse. We measured Brain-derived neurotrophic factor (BDNF) and dopamine D3 receptor (Drd3) expressions in rat brain regions that have been involved in drug-conditioning. Acute cocaine produced a transient increase in BDNF mRNA in the prefrontal cortex, associated with a long-lasting increase in drd3 mRNA, and a delayed and long-lasting increase in Drd3 protein in the nucleus accumbens. Methamphetamine and morphine, two drugs known to easily induce drug-conditioning, also markedly elevated BDNF mRNA. Nicotine had more limited effects. Abused drugs increase acutely BDNF expression, which leads to subsequent long-lasting elevation of Drd3 in the nucleus accumbens that may facilitate responding to drug-associated stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671872     DOI: 10.1097/00001756-200502080-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  73 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain.

Authors:  Deirdre M McCarthy; Xuan Zhang; Shayna B Darnell; Gavin R Sangrey; Yuchio Yanagawa; Ghazaleh Sadri-Vakili; Pradeep G Bhide
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

3.  Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  Behav Brain Res       Date:  2015-08-11       Impact factor: 3.332

4.  TrkB signaling is required for behavioral sensitization and conditioned place preference induced by a single injection of cocaine.

Authors:  Kristy R Crooks; Daniel T Kleven; Ramona M Rodriguiz; William C Wetsel; James O McNamara
Journal:  Neuropharmacology       Date:  2010-02-20       Impact factor: 5.250

Review 5.  [Future medications for tobacco and cannabis dependence].

Authors:  Bernard Le Foll; Zuzana Justinova; Gianlugi Tanda; Steven R Goldberg
Journal:  Bull Acad Natl Med       Date:  2008-01       Impact factor: 0.144

6.  Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.

Authors:  Isabelle Boileau; Doris Payer; Pablo M Rusjan; Sylvain Houle; Junchao Tong; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2016-06-29       Impact factor: 7.853

7.  Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance.

Authors:  Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

8.  Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  Neuroreport       Date:  2009-04-22       Impact factor: 1.837

9.  Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo.

Authors:  Tobias Gyárfás; Juha Knuuttila; Päivi Lindholm; Tomi Rantamäki; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

Review 10.  Molecular and genetic substrates linking stress and addiction.

Authors:  Lisa A Briand; Julie A Blendy
Journal:  Brain Res       Date:  2009-11-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.